Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-10-055718
Filing Date
2010-11-15
Accepted
2010-11-15 18:05:53
Documents
1
Period of Report
2010-11-15

Document Format Files

Seq Description Document Type Size
1 rrd291087.html 3  
1 rrd291087.xml 3 1459
  Complete submission text file 0001181431-10-055718.txt   3364
Mailing Address C?O GUILFORD PHARMACEUTICALS INC 6611 TRIBUTARY STREET BALTIMORE MD 21224
Business Address
Spengler William (Reporting) CIK: 0001297399 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-53290 | Film No.: 101194476

Mailing Address 10005 MUIRLANDS BLVD. STE. G, FIRST FLOOR IRVINE CA 92618
Business Address 10005 MUIRLANDS BLVD. STE. G, FIRST FLOOR IRVINE CA 92618 949-419-0288
ChromaDex Corp. (Issuer) CIK: 0001386570 (see all company filings)

EIN.: 205339393 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products